fbpx

Exits

EpiTherapeutics

Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics.

Invested in 2010

Acquired by Gilead in 2015

Based in Foster City, California, USA 

Lundbeckfonden Emerge

News

23 Danish biotech companies meet investors in New York
3. April 2019
SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials
11. March 2019
Andreas Jurgeit
New Partner joins Lundbeckfonden Emerge
17. December 2018